Showing results (91-100 of 189,432) with videos related to

Sort By:
Pageof 18,944
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer modelsK Fujimoto-Ouchi, Y Tanaka, T Tominaga
Cancer Chemotherapy and Pharmacology|April 6, 2002
Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5'-dFUrd in human breast cancer modelsKaori Fujimoto-Ouchi, Fumiko Sekiguchi, Yutaka Tanaka
Genomics|February 15, 1997
Chromosomal mapping of the mouse and rat brt genesY Matsuda, T Saito, J Fujimoto, et al.
Nucleic Acids Research. Supplement (2001)|July 3, 2003
Template directed DNA photoligation via substituted 2'-deoxyuridineK Fujimoto, N Ogawa, S Matsuda, et al.
Brain & Development|October 24, 2000
Ictal increased writing preceded by dysphasic seizuresT Ishikawa, M Saito, S Fujimoto, et al.
The Journal of General and Applied Microbiology|April 7, 2006
Trans fatty acids promote the growth of some Lactobacillus strainsYasushi Endo, Shusuke Kamisada, Kenshiro Fujimoto, et al.
Heart (British Cardiac Society)|February 4, 2016
Clinical importance of detecting exaggerated blood pressure response to exercise on antihypertensive therapyReiko Mizuno, Shinichi Fujimoto, Yoshihiko Saito, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Microbes Culture System Using Cellulose Tubes and Photocatalyst-Coated Glass BallsK Saito, K Fujimoto, K Higashi, et al.
Nihon Naibunpi Gakkai Zasshi|May 20, 1988
[Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex]T Masuda, H Fujimoto, H Kawai, et al.
Hypertension (Dallas, Tex. : 1979)|July 4, 2012
Optimal antihypertensive level for improvement of coronary microvascular dysfunction: the lower, the better?Reiko Mizuno, Shinichi Fujimoto, Yoshihiko Saito, et al.
Pageof 18,944